<?xml version="1.0" encoding="UTF-8"?>
<EXPERIMENT_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <EXPERIMENT accession="ERX6625741" alias="E-MTAB-11055:OVOL2_1_p" broker_name="ArrayExpress" center_name="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX6625741</PRIMARY_ID>
      <SUBMITTER_ID namespace="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">E-MTAB-11055:OVOL2_1_p</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>NextSeq 500 paired end sequencing; RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</TITLE>
    <STUDY_REF accession="ERP132464">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP132464</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJEB48143</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="ERS8032930">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS8032930</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA10378356</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>OVOL2_1_p</LIBRARY_NAME>
        <LIBRARY_STRATEGY>ssRNA-seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>Inverse rRNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>Cells were collected after 24 hours from the induction of OVOL2 expression (by doxycycline). Cells were cultured in RPMI medium supplemented with 10% FBS and 1% P/S. Total RNA was extracted by Maxwell RSC simplyRNA Cells kit (Promega, Madison, Wisconsin, USA) Libraries were obtained starting from 100ng of total RNA following the Illumina Stranded Total RNA preparation Ligation with Ribo-Zero Plus protocol.</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>NextSeq 500</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: phenotype</TAG>
        <VALUE>doxycycline-mediated expression of OVOL2</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT accession="ERX6625740" alias="E-MTAB-11055:EV_3_p" broker_name="ArrayExpress" center_name="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX6625740</PRIMARY_ID>
      <SUBMITTER_ID namespace="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">E-MTAB-11055:EV_3_p</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>NextSeq 500 paired end sequencing; RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</TITLE>
    <STUDY_REF accession="ERP132464">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP132464</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJEB48143</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="ERS8032929">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS8032929</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA10378355</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>EV_3_p</LIBRARY_NAME>
        <LIBRARY_STRATEGY>ssRNA-seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>Inverse rRNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>Cells were collected after 24 hours from the induction of OVOL2 expression (by doxycycline). Cells were cultured in RPMI medium supplemented with 10% FBS and 1% P/S. Total RNA was extracted by Maxwell RSC simplyRNA Cells kit (Promega, Madison, Wisconsin, USA) Libraries were obtained starting from 100ng of total RNA following the Illumina Stranded Total RNA preparation Ligation with Ribo-Zero Plus protocol.</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>NextSeq 500</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: phenotype</TAG>
        <VALUE>wild type</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT accession="ERX6625743" alias="E-MTAB-11055:OVOL2_3_p" broker_name="ArrayExpress" center_name="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX6625743</PRIMARY_ID>
      <SUBMITTER_ID namespace="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">E-MTAB-11055:OVOL2_3_p</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>NextSeq 500 paired end sequencing; RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</TITLE>
    <STUDY_REF accession="ERP132464">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP132464</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJEB48143</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="ERS8032932">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS8032932</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA10378358</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>OVOL2_3_p</LIBRARY_NAME>
        <LIBRARY_STRATEGY>ssRNA-seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>Inverse rRNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>Cells were collected after 24 hours from the induction of OVOL2 expression (by doxycycline). Cells were cultured in RPMI medium supplemented with 10% FBS and 1% P/S. Total RNA was extracted by Maxwell RSC simplyRNA Cells kit (Promega, Madison, Wisconsin, USA) Libraries were obtained starting from 100ng of total RNA following the Illumina Stranded Total RNA preparation Ligation with Ribo-Zero Plus protocol.</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>NextSeq 500</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: phenotype</TAG>
        <VALUE>doxycycline-mediated expression of OVOL2</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT accession="ERX6625738" alias="E-MTAB-11055:EV_1_p" broker_name="ArrayExpress" center_name="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX6625738</PRIMARY_ID>
      <SUBMITTER_ID namespace="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">E-MTAB-11055:EV_1_p</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>NextSeq 500 paired end sequencing; RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</TITLE>
    <STUDY_REF accession="ERP132464">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP132464</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJEB48143</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="ERS8032927">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS8032927</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA10378353</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>EV_1_p</LIBRARY_NAME>
        <LIBRARY_STRATEGY>ssRNA-seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>Inverse rRNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>Cells were collected after 24 hours from the induction of OVOL2 expression (by doxycycline). Cells were cultured in RPMI medium supplemented with 10% FBS and 1% P/S. Total RNA was extracted by Maxwell RSC simplyRNA Cells kit (Promega, Madison, Wisconsin, USA) Libraries were obtained starting from 100ng of total RNA following the Illumina Stranded Total RNA preparation Ligation with Ribo-Zero Plus protocol.</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>NextSeq 500</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: phenotype</TAG>
        <VALUE>wild type</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT accession="ERX6625739" alias="E-MTAB-11055:EV_2_p" broker_name="ArrayExpress" center_name="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX6625739</PRIMARY_ID>
      <SUBMITTER_ID namespace="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">E-MTAB-11055:EV_2_p</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>NextSeq 500 paired end sequencing; RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</TITLE>
    <STUDY_REF accession="ERP132464">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP132464</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJEB48143</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="ERS8032928">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS8032928</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA10378354</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>EV_2_p</LIBRARY_NAME>
        <LIBRARY_STRATEGY>ssRNA-seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>Inverse rRNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>Cells were collected after 24 hours from the induction of OVOL2 expression (by doxycycline). Cells were cultured in RPMI medium supplemented with 10% FBS and 1% P/S. Total RNA was extracted by Maxwell RSC simplyRNA Cells kit (Promega, Madison, Wisconsin, USA) Libraries were obtained starting from 100ng of total RNA following the Illumina Stranded Total RNA preparation Ligation with Ribo-Zero Plus protocol.</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>NextSeq 500</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: phenotype</TAG>
        <VALUE>wild type</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT accession="ERX6625742" alias="E-MTAB-11055:OVOL2_2_p" broker_name="ArrayExpress" center_name="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX6625742</PRIMARY_ID>
      <SUBMITTER_ID namespace="Laboratory of Traslational Research. Azienda USL-IRCCS di Reggio Emilia">E-MTAB-11055:OVOL2_2_p</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>NextSeq 500 paired end sequencing; RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</TITLE>
    <STUDY_REF accession="ERP132464">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP132464</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJEB48143</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>RNA-seq of anaplastic thyroid carcinoma cell line (8505c) after overexpression of OVOL2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="ERS8032931">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS8032931</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA10378357</EXTERNAL_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>OVOL2_2_p</LIBRARY_NAME>
        <LIBRARY_STRATEGY>ssRNA-seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>Inverse rRNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>Cells were collected after 24 hours from the induction of OVOL2 expression (by doxycycline). Cells were cultured in RPMI medium supplemented with 10% FBS and 1% P/S. Total RNA was extracted by Maxwell RSC simplyRNA Cells kit (Promega, Madison, Wisconsin, USA) Libraries were obtained starting from 100ng of total RNA following the Illumina Stranded Total RNA preparation Ligation with Ribo-Zero Plus protocol.</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>NextSeq 500</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: phenotype</TAG>
        <VALUE>doxycycline-mediated expression of OVOL2</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
</EXPERIMENT_SET>
